Atai stock forecast.

View the latest ATAI Life Sciences N.V. (ATAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.3. 4. 2023. ... As atai currently has a stock price of $1.83 and a market cap of $304 million. Meaning it is trading at a 14% discount. And again, that ...ATAI Life Sciences NV (ATAI) stock is trading at $2.17 as of 1:48 PM on Monday, Jul 17, a gain of $0.15, or 7.55% from the previous closing price of $2.02. The stock has traded between $2.00 and $2.20 so far …12. 1. 2023. ... After atai Life Sciences (NASDAQ:ATAI) shared the results of subsidiary ... The closing stock price on Jan. 11 was $1.72, more than 90% below ...

111.91%. Get the latest ATAI Life Sciences NV (ATAI) real-time quote, historical performance, charts, and other financial information to help you make more informed …Web

Atai Life Sciences. ... Further clinical trial data will create volatility in CMPS stock. COMPASS Pathways 1-year price chart ... registering a CAGR of 16.8% during the forecast period of 2022 to ...Oct 24, 2023 · That said, analysts are starting to come around on ATAI. H.C. Wainwright biotech analyst Patrick Trucchio maintained a "buy" rating on Atai in early October, with a price target of $20. Its ...

Find real-time ATAI - ATAI Life Sciences NV stock quotes, company profile, news and forecasts from CNN Business.Get ATAI Life Sciences NV (ATAI.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsAs such, ATAI has been trading -1490.91% off suggested target high and -286.36% from its likely low. ATAI Life Sciences N.V. (ATAI) estimates and forecasts. Looking at statistics comparing ATAI Life Sciences N.V. share performance against respective industry, we note that the company has outperformed competitors.In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.

STRO Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Sutro Biopharma in the last 3 months. The average price target is $13.40 with a high forecast of $17.00 and a low forecast of $10.00. The average price target represents a 396.30% change from the last price of $2.70.

CMPS Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for COMPASS Pathways in the last 3 months. The average price target is $50.17 with a high forecast of $120.00 and a low forecast of $21.00. The average price target represents a 832.53% change from the last price of $5.38.

According to 6 analyst offering 12-month price targets in the last 3 months, ATAI Life Sciences has an average price target of $15.33 with a high of $23.00 and a low of $9.00. Below is a summary ...15. 6. 2021. ... Since Atai Life Sciences is only going public, we don't have any forecast for the stock. Also, being a clinical-stage company, we don't have ...Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...28.98. According to our current ATAI stock forecast, the value of Atai Life Sciences N.V. shares will drop by -18.90% and reach $ 0.875911 per share by December 3, 2023. …Web23 brokers have issued 1 year price targets for Advanced Micro Devices' shares. Their AMD share price targets range from $80.00 to $200.00. On average, they expect the company's share price to reach $134.77 in the next twelve months. This suggests a possible upside of 11.0% from the stock's current price.As of last trade ATAI Life Sciences NV (ATAI:NMQ) traded at 1.10, 4.76% above its 52-week low of 1.05, set on Oct 27, 2023. Data delayed at least 15 minutes, as of Nov 30 2023 18:35 GMT. Latest ATAI Life Sciences NV (ATAI:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and …

Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Find real-time CRM - Salesforce Inc stock quotes, company profile, news and forecasts from CNN Business.(See ATAI stock forecast on TipRanks) SomaLogic . The next Wood pick we’ll look at is a protein biomarker discovery and clinical diagnostics company.Find the latest AFC Gamma, Inc. (AFCG) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Super Micro Computer Inc have a median target of 397.00, with a high estimate of 500.00 and a low estimate of 240.00 ...

Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $214.15M. -60.0%. Market Cap / Employee. The market cap of a ...

ATAI Life Sciences N.V. Watch Set a price target alert Premarket Last Updated: Nov 15, 2023 8:18 a.m. EST Delayed quote $ 1.2900 0.04 2.79% Before Hours Volume: 2.23K …WebOn December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until the 2024 annual meeting of the Company’s stockholders, or until their respective successors are duly elected and qualified.Atai Life Sciences ( ATAI 2.80%), a small-cap drugmaker developing psychedelic-based treatments for drug dependency and mental health disorders, posted strong gains during the first four days of ...Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $214.15M. -60.0%. Market Cap / Employee. The market cap of a ...Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are ...ATAI Life Sciences NV. $1.12. ATAI 7.69% ; Enveric Biosciences Inc. $1.68. ENVB 13.51% ; Compass Pathways PLC. $6.10. CMPS 2.01% ; ehave Inc. $0.0017. EHVVF 0.00%.30. 8. 2022. ... Wall Street's 12-month median price forecast for ATAI stock stands at $24.50. Compass Pathways (CMPS). magic mushrooms representing champion ...ATAI Life Sciences N.V. stock price forecast for further price development down to -32.20% (time horizon: 1 day) and price target of 1.11 USD. Short-term (time horizon: 2 weeks) ATAI Life Sciences N.V. share price prediction for 2024-01-12 with daily closed price projectionsATAI Life Sciences. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01 ...We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...

Find real-time SMCI - Super Micro Computer Inc stock quotes, company profile, news and forecasts from CNN Business.

Find real-time DTIL - Precision BioSciences Inc stock quotes, company profile, news and forecasts from CNN Business.

Find real-time NEE - Nextera Energy Inc stock quotes, company profile, news and forecasts from CNN Business.ADMA Stock 12 Months Forecast. $6.00. (51.90% Upside) Based on 2 Wall Street analysts offering 12 month price targets for ADMA Biologics in the last 3 months. The average price target is $6.00 with a high forecast of $7.00 and a low forecast of $5.00. The average price target represents a 51.90% change from the last price of $3.95.The stock has given up three-quarters of its market value year to date. Ark Genomic bought 67,384 shares of Atai Life Sciences - Get Free Report, valued at $284,360. Atai is a Berlin ...Price target. 13.80 0.00 0.00%. The 5 analysts offering 1 year price forecasts for ATAI have a max estimate of — and a min estimate of —.ATAI stock is down 44% year-to-date (YTD), despite a 10% increase over the past month. Shares are changing hands at 2.4x book value. Wall Street’s 12-month median price forecast for ATAI stock ...Track ATAI Life Sciences N.V. (ATAI) Stock Price, Quote, latest community messages, chart, news and other stock related information.ATAI Life Sciences. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01 ... A list of all stock splits on the US stock market in 2023, including both regular (forward) and reverse splits.111.91%. Get the latest ATAI Life Sciences NV (ATAI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...

Atai Life Sciences. ... Further clinical trial data will create volatility in CMPS stock. COMPASS Pathways 1-year price chart ... registering a CAGR of 16.8% during the forecast period of 2022 to ...Read an investment analysis of ATAI stock here. ... By 2029, it is forecast to be worth $7.2 billion globally, with a compound annual growth rate of 55%. Also, ...WebATAI Life Sciences NV Stock Forecast. Is ATAI Life Sciences NV Stock Undervalued? The current ATAI Life Sciences NV [ ATAI] share price is $1.06. The Score for ATAI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. ATAI is currently trading in the 10-20% percentile range relative to its historical ...Instagram:https://instagram. best cryptocurrency trackerwebull stock simulatortd withdrawal limit atmsavvy insurance quotes Atai Life Sciences Announces Results from the Phase 1 Iv-To-Subcutaneous Bridging Study of Pcn-101 (R-Ketamine) Aug. 08: CI Atai Life Sciences N.V., Atai Life Sciences AG Enters into the Second Amendment to Loan and Security Agreement with the Several Banks May. 31: CINovember 30, 2023. EPS forecast (this quarter) -$1.25. Annual revenue (last year) $244.7M. Annual profit (last year) -$358.7M. Net profit margin. qyld yieldbest propfirm Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $214.15M. -60.0%. Market Cap / Employee. The market cap of a ...People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing. stock swks ATAI Life Sciences. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01 ... That said, analysts are starting to come around on ATAI. H.C. Wainwright biotech analyst Patrick Trucchio maintained a "buy" rating on Atai in early October, with a price target of $20. Its ...